期刊文献+

肺炎支原体肺炎患儿血清TNF-α IL-6 IL-10的水平检测及其临床意义 被引量:18

Detection and Significance of Serum TNF-α IL-6 and IL-10 in Children with Mycoplasma Pneumoniae Pneumonia
下载PDF
导出
摘要 目的:探讨支原体肺炎患儿血清中细胞因子、肿瘤坏死因子-α、白细胞介素-6、白细胞介素-10在其发病及肺外损害中的作用与意义。方法:将40例支原体肺炎患儿按病情轻重分为两组,20例为轻型支原体肺炎,20例为重症支原体肺炎。正常对照组20例。采用酶联免疫吸附法(ELISA法)测定患儿急性期血清中肿瘤坏死因子-α、白细胞介素-6、白细胞介素-10的水平。结果:支原体肺炎患儿血清肿瘤坏死因子-α、白细胞介素-6、白细胞介素-10水平在发病急性期明显高于正常对照组,且重症支原体肺炎高于轻型支原体肺炎,P均<0.05,差异均有统计学意义。结论:支原体肺炎病变越严重,急性期血清肿瘤坏死因子-α、白细胞介素-6、白细胞介素-10水平越高。因此检测血清中肿瘤坏死因子-α、白细胞介素-6、白细胞介素-10的水平可作为监测支原体肺炎严重程度及有无合并症的指标。 Objective:To evaluate the relationship between cellular cytokine levels(TNF-α、IL-6 and IL-10)and mycoplasma pneumonia in children.Methods: Forty cases of mycoplasma pneumonia were divided into two groups which twenty cases were severe mycoplasma pneumonia and twenty cases were common mycoplasma pneumonia.Twenty more cases were chosen as normal control.The levels of cellular cytokine(TNF-α、IL-6 and IL-10)in the serum of mycoplasma pneumonia were determined by ELISA.Results: The levels of cellular cvtokine(TNF-α、IL-6 and IL-10)were significant higher in severe mycoplasma pneumonia at acut ephase than those in common mycoplasma pneumonia and control group.P<0.05.Conclusions: The levels of cellular cytokine(TNF-α、IL-6 and IL-10) were a reliable marker in evaluating the severity and having complication or not of mycoplasma pneumonia.
出处 《内蒙古医学杂志》 2007年第11期1287-1288,共2页 Inner Mongolia Medical Journal
关键词 支原体肺炎 肿瘤坏死因子-α 白细胞介素-6 白细胞介素-10 Mycoplasma pneumonia Tumor necrosis factor-α Interleukin-6 Interleukin-10
  • 相关文献

参考文献5

二级参考文献25

  • 1[1]Ishida T,Hashimoto M,Arita I,et al.Etiology of community-acquired pneumonia in hospitalized patients:a 3-year prospective study in Japan.Chest,1998,114(6):1588-1593
  • 2[3]Lucier TS,Heitzman K,Liu SK,et al.Transition mutations in the 23SrRNA of erythromycin-resistant isolates of Mycoplasma pneumonia.Antimicrob Agents Chemother,1995,39(12):2770-2773
  • 3[4]Speer BS,Shoemaker NB,Salyers AA.Bacterial resistance to tetracycline:mechanisms,transfer,and clinical significance.Clin Microbiol Rev,1992,5(4):387-399
  • 4[5]Sum PE,Lee VJ,Testa RT,et al.Glycylcyclines.Ⅰ.A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.J Med Chem,1993,37(1):184-188
  • 5[6]Goldstein FW,Kitzis MD,Acar JF.N,N-Dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline,two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocci.Antimicrob Agents Chemother,1994,38(9):2218-2220
  • 6[7]Nord C,Lindmark A,Person I.In vitro activity of DMG-Mino and DMG-Dmdot,two new glycylcyclines,against anaerobic bacteria.Eur J Clin Microbiol Infect Dis,1993,12(11):784-786
  • 7[8]Toshiyuki Y,Yoichi H,Koichi I,et al.In vitro activity of telithromycin(HMR3647),a new ketolide,against clinical isolates of Mycoplasma pneumonia in Japan.Antimicrob Agents Chemother,2000,44(5):1381-1382
  • 8[9]Petersen PJ,Jacobus NV,Weiss WJ,et al.In vitro and in vivo antibacterial activities of a novel glycylcycline,the 9-t-Butylglycylamido Derivative of minocycline(GAR-936).Antimicrob Agents Chemother,1999,43(4):738-744
  • 9[12]戴西湖,谢福安,叶礼燕.临床辨病专方治疗丛书.北京:人民卫生出版社,2000.191-201
  • 10[14]Foy HM,Ochs H,Davis SD,et al.Mycoplasma pneumonia infection in patients with immunodeficiency syndromes:report of four cases.J Infect Dis,1973,127(4):388-393

共引文献97

同被引文献165

引证文献18

二级引证文献264

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部